Skip to Content

Ribasphere Three Rivers Pharmaceuticals - Treatment for Hepatitis C ("HCV")

The U.S. Food and Drug Administration (FDA) has granted marketing approval for Ribasphere (ribavirin capsules) 200mg in combination with interferon alfa-2b for the treatment of Hepatitis C ("HCV").

Ribasphere (ribavirin) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.